vs

Side-by-side financial comparison of Invesco (IVZ) and Molson Coors Beverage Company (TAP). Click either name above to swap in a different company.

Molson Coors Beverage Company is the larger business by last-quarter revenue ($2.7B vs $1.7B, roughly 1.6× Invesco). Molson Coors Beverage Company runs the higher net margin — 5.5% vs -58.9%, a 64.4% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs 2.0%). Invesco produced more free cash flow last quarter ($432.2M vs $-212.9M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs -15.8%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Molson Coors Beverage Company is a Canadian-American multinational drink and brewing company headquartered in Chicago, Illinois and Montreal, Quebec.

IVZ vs TAP — Head-to-Head

Bigger by revenue
TAP
TAP
1.6× larger
TAP
$2.7B
$1.7B
IVZ
Growing faster (revenue YoY)
IVZ
IVZ
+4.2% gap
IVZ
6.2%
2.0%
TAP
Higher net margin
TAP
TAP
64.4% more per $
TAP
5.5%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$645.1M more FCF
IVZ
$432.2M
$-212.9M
TAP
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
-15.8%
TAP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IVZ
IVZ
TAP
TAP
Revenue
$1.7B
$2.7B
Net Profit
$-995.9M
$150.1M
Gross Margin
33.0%
Operating Margin
-86.2%
Net Margin
-58.9%
5.5%
Revenue YoY
6.2%
2.0%
Net Profit YoY
-575.8%
25.0%
EPS (diluted)
$-2.61
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
TAP
TAP
Q1 26
$2.7B
Q4 25
$1.7B
$3.1B
Q3 25
$1.6B
$3.5B
Q2 25
$1.5B
$3.7B
Q1 25
$1.5B
$2.7B
Q4 24
$1.6B
$3.2B
Q3 24
$1.5B
$3.6B
Q2 24
$1.5B
$3.8B
Net Profit
IVZ
IVZ
TAP
TAP
Q1 26
$150.1M
Q4 25
$-995.9M
$238.3M
Q3 25
$356.4M
$-2.9B
Q2 25
$197.4M
$428.7M
Q1 25
$171.1M
$121.0M
Q4 24
$209.3M
$287.8M
Q3 24
$55.0M
$199.8M
Q2 24
$132.2M
$427.0M
Gross Margin
IVZ
IVZ
TAP
TAP
Q1 26
33.0%
Q4 25
31.0%
Q3 25
33.7%
Q2 25
34.3%
Q1 25
31.6%
Q4 24
32.0%
Q3 24
33.4%
Q2 24
34.6%
Operating Margin
IVZ
IVZ
TAP
TAP
Q1 26
Q4 25
-86.2%
10.4%
Q3 25
16.5%
-98.5%
Q2 25
14.1%
15.6%
Q1 25
18.1%
6.9%
Q4 24
19.6%
12.0%
Q3 24
6.6%
12.5%
Q2 24
13.9%
15.6%
Net Margin
IVZ
IVZ
TAP
TAP
Q1 26
5.5%
Q4 25
-58.9%
7.6%
Q3 25
21.7%
-84.0%
Q2 25
13.0%
11.5%
Q1 25
11.2%
4.5%
Q4 24
13.1%
8.9%
Q3 24
3.6%
5.5%
Q2 24
8.9%
11.1%
EPS (diluted)
IVZ
IVZ
TAP
TAP
Q1 26
$0.80
Q4 25
$-2.61
$1.32
Q3 25
$0.66
$-14.79
Q2 25
$-0.03
$2.13
Q1 25
$0.38
$0.59
Q4 24
$0.46
$1.39
Q3 24
$0.12
$0.96
Q2 24
$0.29
$2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
TAP
TAP
Cash + ST InvestmentsLiquidity on hand
$1.0B
$382.6M
Total DebtLower is stronger
$1.8B
$3.8B
Stockholders' EquityBook value
$12.2B
$10.3B
Total Assets
$27.1B
$22.4B
Debt / EquityLower = less leverage
0.15×
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
TAP
TAP
Q1 26
$382.6M
Q4 25
$1.0B
$896.5M
Q3 25
$973.1M
$950.2M
Q2 25
$922.7M
$613.8M
Q1 25
$821.7M
$412.7M
Q4 24
$986.5M
$969.3M
Q3 24
$1.0B
$1.0B
Q2 24
$878.5M
$1.6B
Total Debt
IVZ
IVZ
TAP
TAP
Q1 26
$3.8B
Q4 25
$1.8B
$6.3B
Q3 25
$1.6B
$6.3B
Q2 25
$1.9B
$6.3B
Q1 25
$964.8M
$6.2B
Q4 24
$890.6M
$6.1B
Q3 24
$890.3M
$6.2B
Q2 24
$890.1M
$7.0B
Stockholders' Equity
IVZ
IVZ
TAP
TAP
Q1 26
$10.3B
Q4 25
$12.2B
$10.2B
Q3 25
$14.0B
$10.3B
Q2 25
$13.9B
$13.4B
Q1 25
$14.7B
$13.1B
Q4 24
$14.6B
$13.1B
Q3 24
$14.8B
$13.3B
Q2 24
$14.6B
$13.2B
Total Assets
IVZ
IVZ
TAP
TAP
Q1 26
$22.4B
Q4 25
$27.1B
$22.7B
Q3 25
$28.4B
$22.9B
Q2 25
$28.5B
$26.8B
Q1 25
$28.1B
$25.9B
Q4 24
$27.0B
$26.1B
Q3 24
$27.5B
$26.6B
Q2 24
$27.2B
$27.4B
Debt / Equity
IVZ
IVZ
TAP
TAP
Q1 26
0.38×
Q4 25
0.15×
0.61×
Q3 25
0.12×
0.61×
Q2 25
0.14×
0.47×
Q1 25
0.07×
0.47×
Q4 24
0.06×
0.47×
Q3 24
0.06×
0.47×
Q2 24
0.06×
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
TAP
TAP
Operating Cash FlowLast quarter
$455.8M
Free Cash FlowOCF − Capex
$432.2M
$-212.9M
FCF MarginFCF / Revenue
25.5%
-7.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$1.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
TAP
TAP
Q1 26
Q4 25
$455.8M
$540.7M
Q3 25
$606.2M
$616.1M
Q2 25
$547.9M
$718.3M
Q1 25
$-84.6M
$-90.7M
Q4 24
$316.9M
$494.5M
Q3 24
$438.4M
$521.2M
Q2 24
$489.1M
$869.2M
Free Cash Flow
IVZ
IVZ
TAP
TAP
Q1 26
$-212.9M
Q4 25
$432.2M
$357.8M
Q3 25
$586.4M
$483.0M
Q2 25
$530.4M
$555.0M
Q1 25
$-108.0M
$-328.0M
Q4 24
$309.9M
$383.4M
Q3 24
$410.0M
$350.4M
Q2 24
$462.4M
$691.7M
FCF Margin
IVZ
IVZ
TAP
TAP
Q1 26
-7.8%
Q4 25
25.5%
11.4%
Q3 25
35.7%
13.9%
Q2 25
35.0%
14.8%
Q1 25
-7.1%
-12.2%
Q4 24
19.5%
11.8%
Q3 24
27.1%
9.7%
Q2 24
31.2%
18.0%
Capex Intensity
IVZ
IVZ
TAP
TAP
Q1 26
Q4 25
1.4%
5.9%
Q3 25
1.2%
3.8%
Q2 25
1.2%
4.4%
Q1 25
1.5%
8.8%
Q4 24
0.4%
3.4%
Q3 24
1.9%
4.7%
Q2 24
1.8%
4.6%
Cash Conversion
IVZ
IVZ
TAP
TAP
Q1 26
Q4 25
2.27×
Q3 25
1.70×
Q2 25
2.78×
1.68×
Q1 25
-0.49×
-0.75×
Q4 24
1.51×
1.72×
Q3 24
7.97×
2.61×
Q2 24
3.70×
2.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

TAP
TAP

Segment breakdown not available.

Related Comparisons